Myc coordinates transcription and translation to enhance transformation and suppress invasiveness

Ran Elkon1, Fabricio Loayza-Puch2, Gozde Korkmaz2

  • 1Division of Biological Stress Response, The Netherlands Cancer Institute, Amsterdam, The Netherlands r.agami@nki.nl r.elkon@nki.nl.

EMBO Reports
|November 6, 2015
PubMed

Insights

The proto-oncogene Myc regulates both transcription and translation, impacting cancer cell growth and metastasis. This study reveals how Myc coordinates these processes, influencing oncogenic transformation and cell migration.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • c-Myc is a proto-oncogene linked to tumor aggression and poor outcomes.
  • Myc paradoxically suppresses cell motility, invasiveness, and metastasis.
  • Myc induces protein synthesis machinery, enhancing tumor cell growth.

Purpose of the Study:

  • To investigate whether Myc activation modulates translation of specific genes beyond global protein synthesis enhancement.
  • To comprehensively analyze Myc-induced changes in gene expression at transcription, translation, and protein levels.

Main Methods:

  • Global gene expression analysis at transcription, translation, and protein levels.
  • Assessment of Myc-induced changes in protein synthesis.
  • Investigation of signaling pathways including mTOR and TGFβ.

Main Results:

  • Myc activation extensively regulates protein translation specific to transcripts.
  • A strong coordination between transcription and translation regulation was observed upon Myc modulation.
  • These responses are linked to mTOR signaling for oncogenic transformation and TGFβ for cell migration.

Conclusions:

  • Myc activation leads to transcript-specific translation regulation, not just global protein synthesis increase.
  • Coordinated regulation of transcription and translation by Myc influences cancer progression.
  • Understanding these mechanisms provides novel insights into Myc's role in cancer cells.

Related Concept Videos

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.3K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
8.0K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.3K